oryeongsan: Clinical Trials

1 trial of oryeongsan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow oryeongsan: new trials by email Literature Review of oryeongsan trials Research Report on oryeongsan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GOREISAN for Heart Failure (GOREISAN-HF) Trial
Goreisan, Standard Treatment - Heart Failure, Edema
Phase 4Active not recruitingTakeshi Morimoto11792021-01-192026-01-06

Conditions studied

Edema (1)  ·  Heart Failure (1)

Sponsors

Takeshi Morimoto (1)

Countries

Japan (1)

Top investigators

Takeshi Kimura, MD, PhD (1)

Results publications

PMID 36841318